Instituto Oftalmologico Fernandez-Vega S.L.

Oviedo 14 trials 6 recruiting

14 Registered trials

6 Currently recruiting

Organisation

Instituto Oftalmologico Fernandez-Vega S.L.

Location

Oviedo, Spain

Identifier

ORG-100029388

Address

Principado De Asturias, Avenida Doctores Fernandez Vega 34, 33012, Spain

Departments

Instituto Oftalmologico Fernandez-Vega
Ocular Surface & Inflammation Clinical Unit
Oftalmología
Ophtalmology
Ophthalmology
Ophthlamology
Retina

Clinical trials at this site (14)

Search interface

Randomized clinical trial to evaluate the use of PRGF eye drops in patients with dry eye disease Not authorised

2023-507357-15-00 Dry Eye Disease 6
Randomized clinical trial to evaluate the use of PRGF eye drops in patients with dry eye disease Pending

2023-507357-15-01 Dry Eye Disease 6
EFFICACY OF FARICIMAB IN PATIENTS WITH SUBRETINAL HYPER-REFLECTIVE MATERIAL Recruiting

2025-522701-38-00 SUBRETINAL HYPERREFLECTIVE MATERIAL 6 2026-02-26
Study to Assess the Injection Burden, Safety, Efficacy, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec (ABBV-RGX-314) … Recruiting

2024-512298-28-00 Neovascular age-related macular degeneration 11 2025-12-18
A Phase 3, Multi-Center, Randomized, Parallel, Double Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.1% RG… Recruiting

2024-518969-98-00 Neurotrophic Keratopathy 5 2025-11-04
A phase IV, multicentre, open-label, single-arm study to investigate the efficacy, safety and durability of faricimab (RO6867461) in caucasi… Recruiting

2024-515640-22-00 polypoidal choroidal vasculopathy 6 2025-08-06
A clinical trial to evaluate the safety and the efficacy of NEXAGON ® (Lufepirsen Ophthalmic Gel) in subjects with Persistent Corneal Epithe… Recruiting

2023-507030-24-00 Persistent Corneal Epithelial Defects 4 2025-04-30
A multicentric, randomized, double-blind, placebo-controlled trial to evaluate the efficacy of COLIRIOBCN070660 administered topically in pa… Recruiting

2023-505791-30-01 Diabetic Retinopathy 10 2024-04-17
A Study to Evaluate Long-Term Safety and Tolerability of the Port Delivery System with Ranibizumab in Patients with Neovascular Age-Related … Ended

2023-507131-38-00 Neovascular Age-Related Macular Degeneration (nAMD) 5 2022-05-16
A Study of the Efficacy, Safety, and Pharmacokinetics of A 36-Week Refill Regimen for the Port Delivery System with Ranibizumab in Patients … Ended

2023-507130-24-00 Neovascular age-related macular degeneration (nAMD) 5 2021-10-22
SEER-3: A Phase 3, Multi-Center, Randomized, Parallel, Double Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of… Ended

2022-502697-16-00 Neurotrophic Keratopathy 5 2023-08-29
A Phase 3 Study to Investigate the Safety and Efficacy of Ripasudil (K-321) in Subjects with Fuchs Dystrophy Ended

2022-502643-35-00 Fuchs Endothelial Corneal Dystrophy 5 2023-08-09
A Study to Investigate the Safety and Effectiveness of Ripasudil (K-321) Eye Drops After Descemetorhexis in Subjects with Fuchs Endothelial … Ended

2024-511752-40-00 Fuchs Endothelial Corneal Dystrophy 5 2023-05-05
A clinical study of OPT-302 with aflibercept compared to aflibercept alone in patients with neovascular age-related macular degeneration Ended

2024-512880-30-00 Neovascular Age-related Macular Degeneration (wet AMD) 5 2021-08-27